期刊文献+

人结肠癌细胞中TGF-β1基因-509 C>T单核苷酸多态性对启动转录活性的影响 被引量:1

Influence of-509 C>T single-nucleotide polymorphism on the transcriptional activity of transforming growth factor-beta 1 gene in human colorectal cancer cells
下载PDF
导出
摘要 目的探讨在人结肠癌细胞中转化生长因子β1(TGF-β1)基因上游启动子-509 C>T位点多态性对其转录活性的影响。方法以特定-509 C>T基因型患者DNA为模板,用聚合酶链反应(PCR)扩增得到1对长度为2.14 kb(-1 328^+812)含有-509 C>T变异的TGF-β1上游基因片段,并将其与不含启动子的pCAT3-enhancer报告基因载体重组,构建重组体phTGF 2.14C和phTGF 2.14T。用脂质体转染法将2种重组体分别转染至人结肠癌细胞(SW480和LoVo细胞)中,酶联免疫吸附试验(ELISA)测定转染细胞的报告基因CAT活性。结果在SW480和LoVo细胞中,转染重组体phTGF 2.14C细胞的CAT活性均明显高于转染重组体phTGF2.14T细胞的CAT活性(P<0.05)。结论 -509位点C等位基因可明显增强TGF-β1基因上游调控序列的转录活性。 Objective To study the influence of -509 C 〉 T polymorphism on the transcriptional activity of transforming growth factor-beta 1 (TGF-131) gene in human colorectal cancer cells. Methods Sequence -1 328- + 812 (2.14 kb) of TGF-β1 gene containing the -509 C 〉 T was selected as putative promoter by polymerase chain reaction (PCR) amplification. The -1 328-+812 of TGF-β1 gene and pCAT3-enhaneer gene were recombined, and the phTGF 2.14C and phTGF 2.14T were constructed and transfected into human colorectal cancer cells (SW480 and LoVo) by liposomal transfection method. The transfected colorectal cancer cells were collected to analyze the reporter gene CAT activity by enzyme-linked immunosorbent assay (ELISA). Results In SW480 and LoVo cells, reporter gene CAT activity in cells transfected with phTGF 2. 14C was significantly higher than that transfected with phTGF 2. 14T (P 〈 0.05). Conclusions C allele at -509 C 〉 T can increase the promoter activity of TGF--β1 gene in colorectal cancer cells.
出处 《检验医学》 CAS 北大核心 2010年第9期678-682,共5页 Laboratory Medicine
基金 国家自然科学基金(30770994)
关键词 单核苷酸多态性 转化生长因子Β1 启动子 转录活性 结肠癌 Single-nucleotide polymorphism Transforming growth factor-beta 1 Promoter Transcriptional activity Colorectal cancer
  • 相关文献

参考文献2

二级参考文献93

  • 1杨再兴,王皓,高春芳,徐玲玲,赵文静.转化生长因子β1基因多态性对乙型肝炎肝硬化的影响[J].中华医学杂志,2005,85(15):1021-1026. 被引量:28
  • 2Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.Hepatology 2003; 37:493-503.
  • 3Seeff LK Natural history of chronic hepatitis C. Hepatology2002; 36:S35-S46.
  • 4Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36:S47-S56.
  • 5Hoofnagle JH.-Course and Outcome of hepatitis C. Hepatology2002; 36" S21-S29.
  • 6Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
  • 7Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci 2002; 7:D793-D807.
  • 8Castilla A, P-rieto J, Fausto N. Transforming growth factor β 1 and alpha in chronic liver disease. Effects of interferon αtherapy. N Engl J Med 1991; 324:933-940.
  • 9Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL, Lau JY. Transforming growth factor-β 1 inchronic hepatitis C. J Viral Hepat 1997; 4:29-35.
  • 10Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P,Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92:2572-2576.

共引文献25

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部